LLY
Eli Lilly Captures 70% of New Senior Obesity Drug Market Following Medicare Coverage
Eli Lilly CEO Dave Ricks announced that 700,000 seniors have started GLP-1 obesity treatments since Medicare began covering the drugs in July 2026. The company...
